A Study of Multiple Immune and Disease Treatment Combinations in Participants With ER+HER2-Breast Cancer That Has Spread

Condition:   Breast Cancer Interventions:   Drug: nivolumab;   Drug: ipilimumab;   Drug: nab-paclitaxel Sponsor:   Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials